INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 119 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $99,000 | -90.7% | 74,700 | -44.7% | 0.00% | -93.8% |
Q4 2015 | $1,061,000 | +0.5% | 135,200 | +8.2% | 0.02% | 0.0% |
Q3 2015 | $1,056,000 | +15.8% | 125,000 | +50.1% | 0.02% | +14.3% |
Q2 2015 | $912,000 | +57.2% | 83,300 | +100.7% | 0.01% | +55.6% |
Q1 2015 | $580,000 | – | 41,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 15,232,268 | $29,094,000 | 2.84% |
EcoR1 Capital, LLC | 412,000 | $787,000 | 0.08% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,130,432 | $2,159,000 | 0.05% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 164,605 | $314,000 | 0.04% |
Clear Harbor Asset Management, LLC | 95,630 | $183,000 | 0.03% |
ALGERT GLOBAL LLC | 72,556 | $139,000 | 0.03% |
180 WEALTH ADVISORS, LLC | 30,000 | $57,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 289,854 | $554,000 | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 85,412 | $163,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 459,000 | $877,000 | 0.01% |